Volume 26 (2023)
Volume 25 (2022)
Volume 24 (2021)
Volume 23 (2020)
Volume 22 (2019)
Volume 21 (2018)
Volume 20 (2017)
Volume 19 (2016)
Volume 18 (2015)
Volume 17 (2014)
Volume 16 (2013)
Volume 15 (2012)
Volume 14 (2011)
Volume 13 (2010)
Volume 12 (2009)
Volume 11 (2008)
Volume 10 (2007)
Volume 9 (2006)
Volume 8 (2005)
Volume 7 (2004)
Volume 6 (2002)
Volume 5 (2002)
Volume 4 (2000)
Volume 3 (1999)
Volume 2 (1998)
Volume 1 (1997)
Methicillin-resistant Staphylococcus aureus (MRSA) an important microorganism: determination of its prevalence and evaluation of its associated factors in hospitalized dermatologic patients

Alizadeh Narges; Oskuee Alireza Ba–Eeman; Golchai Javad; Sadre-Eshkevari Shahryar; Darjani Abbas; Kazemnejad Ehsan; Eftekhari Hojat; Mohtasham-Amiri Zahra

Volume 17, Issue 2 , 2014, , Pages 54-58

Abstract
  Background: Methicillin–resistant Staphylococcus aureus (MRSA)has recently emerged as a worldwide major nosocomial pathogenthat causes significant morbidity and mortality. MRSA is frequentlycolonized on the skin. The aim of this study was to determinethe MRSA colonization/infection prevalence and ...  Read More

Frequency of resistance to systemically administered Meglumine Antimoniate (Glucantime) in patients with acute cutaneous Leishmaniasis: A cross-sectional study

MA Nilfroush Zadeh; N Anasri; R Derakhshan

Volume 8, Issue 6 , 2006, , Pages 457-461

Abstract
  Background and aim: Pentavalent antimony compounds are the first line treatment for cutaneous leishmaniasis. Clinical resistance to pentavalent antimony in the form of meglumine antimoniate (Glucantime) has been recognized as a problem in leishmaniasis. Herein, clinical response to Glucantime were studied ...  Read More